Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer

Fig. 7

Immune landscape and molecular expression profiles of the two risk groups. A Differences in immune cell infiltration between the two risk groups; B stromal, immune, and ESTIMATE scores in the two risk groups; C expression of 47 ICMs in the two risk groups; D differences in metabolic and molecular subtypes in immunotherapy between the two risk groups

Back to article page